Year |
Citation |
Score |
2023 |
Jain K, Henrich IC, Quick L, Young R, Mondal S, Oliveira AM, Blobel GA, Chou MM. Natural Killer Cell Activation by Ubiquitin-specific Protease 6 Mediates Tumor Suppression in Ewing Sarcoma. Cancer Research Communications. 3: 1615-1627. PMID 37615015 DOI: 10.1158/2767-9764.CRC-22-0505 |
0.659 |
|
2021 |
Henrich IC, Jain K, Young R, Quick L, Lindsay JM, Park DH, Oliveira AM, Blobel GA, Chou MM. Ubiquitin-specific protease 6 functions as a tumor suppressor in Ewing Sarcoma through immune activation. Cancer Research. PMID 33558334 DOI: 10.1158/0008-5472.CAN-20-1458 |
0.665 |
|
2018 |
Henrich IC, Young R, Quick L, Oliveira AM, Chou MM. USP6 Confers Sensitivity to IFN-Mediated Apoptosis Through Modulation of TRAIL Signaling in Ewing Sarcoma. Molecular Cancer Research : McR. PMID 30131449 DOI: 10.1158/1541-7786.Mcr-18-0289 |
0.67 |
|
2018 |
Henrich I, Young R, Quick L, Wang X, Oliveira A, Chou M. Abstract PR08: Ubiquitin-specific protease 6 (USP6) oncogene confers sensitivity of Ewing sarcoma to interferon cytotoxicity Clinical Cancer Research. 24. DOI: 10.1158/1557-3265.Sarcomas17-Pr08 |
0.66 |
|
2016 |
Quick L, Young R, Henrich IC, Wang X, Asman YW, Oliveira A, Chou MM. Jak1-STAT3 signals are essential effectors of the USP6/TRE17 oncogene in tumorigenesis. Cancer Research. PMID 27440725 DOI: 10.1158/0008-5472.Can-15-2391 |
0.648 |
|
2016 |
Madan B, Walker MP, Young R, Quick L, Orgel KA, Ryan M, Gupta P, Henrich IC, Ferrer M, Marine S, Roberts BS, Arthur WT, Berndt JD, Oliveira AM, Moon RT, et al. USP6 oncogene promotes Wnt signaling by deubiquitylating Frizzleds. Proceedings of the National Academy of Sciences of the United States of America. PMID 27162353 DOI: 10.1073/Pnas.1605691113 |
0.605 |
|
2016 |
Ager C, Reilley M, Nicholas C, Bartkowiak T, Jaiswal A, Curran M, Albershardt TC, Bajaj A, Archer JF, Reeves RS, Ngo LY, Berglund P, ter Meulen J, Denis C, Ghadially H, ... ... Henrich I, et al. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two Journal For Immunotherapy of Cancer. 4. DOI: 10.1186/S40425-016-0173-6 |
0.524 |
|
Show low-probability matches. |